Bio-Rad Launches Nuvia™ IMAC Affinity Resin for Process Scale Purifications at Bioprocess International Conference and Exhibition 2016
Resin To Be Showcased as Part of a Comprehensive Line of Bioprocess Workflow Solutions
Boston, MA — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today released Nuvia™ IMAC Resin, an immobilized metal affinity chromatography resin optimized for use from lab scale through pilot studies to process-scale manufacturing, at the 2016 Bioprocess International Conference and Exhibition, Boston, Oct. 4–7.
Bio-Rad (Booth #1129) will also exhibit a host of customizable workflows designed to simplify and speed up drug discovery and development, including automated multicolumn protein purification, host cell protein and host cell DNA analysis, and CRISPR/Cas9 transfection and monitoring.
A Resin for Any Stage of Drug Discovery and Development
Metal affinity chromatography was developed for the purification of native proteins with an intrinsic affinity to metal ions. Immobilized metal affinity chromatography (IMAC) has a broad range of applications, though its main application is for the p

